As life expectancy continues to rise and demographic aging accelerates, more people are seeking treatments that help them maintain both well-being and a youthful appearance over a longer lifespan. Within this environment, aesthetic dermatology is experiencing particularly strong growth, fueled by rising consumer interest in skin quality and preventive care.

According to the Japanese Society of Aesthetic Plastic Surgery, non-surgical procedures increased from approximately 1.62 million in 2017 to 3.06 million in 2024, with their share of total aesthetic treatments rising from 83% to 88% over the same period, demonstrating both rapid volume growth and a structural shift away from surgical interventions.

SBC is capturing this growth opportunity by accelerating the rollout of efficient, specialized dermatology models that meet rising demand for non-surgical care. “Hada no Aozora Clinic” combines insurance-based and private-pay services to address a full spectrum of dermatological needs, from general skin conditions to advanced aesthetic treatments, creating a welcoming environment for a wide range of patients, including those new to aesthetic medicine.

The clinic complements existing SBC brands such as NEO SKIN CLINIC and JUN CLINIC, enabling the Group to serve patient segments ranging from entry-level to expert users and to build a high-margin, multi-tier portfolio. SBC operates a network of more than 250 clinics worldwide and records over six million patient visits annually. Drawing on its long-standing experience in both private-pay and insurance-based care, the company leverages standardized operations and an established network to maintain a highly efficient, low-cost operating model.

“Demand for aesthetic dermatology has been expanding at a remarkable pace in recent years. Over the years, SBC has steadily built a robust framework to provide a broad range of services across both private-pay and insurance-covered care. Based on this proven track record, we established ‘Hada no Aozora Clinic’ to further advance our Group’s belief in making aesthetic medicine more accessible. This new brand represents an important step forward in SBC Medical Group’s growth strategy, enabling us to meet diverse skin concerns across all generations,” said Yoshiyuki Aikawa, CEO of SBC Medical Group Holdings.